Syneron Sues EndyMed and Eclipse Aesthetics

On Wednesday, October 10, 2012, Syneron (plaintiff) filed a complaint against EndyMed and Eclipse Aesthetics (defendants) for patent infringement in the U.S. District Court of Texas (case no. 3:12-cv-04087).

Syneron Medical is in the business of developing and manufacturing electronic devices and associated products for use in nonsurgical cosmetic procedures. EndyMed designs, develops, and commercializes energy based aesthetic treatment systems for the professional markets. Eclipse is a manufacturer and supplier of aesthetic medical products.

The patents involved in this suit are currently assigned to Syneron and are listed below:

Patent No.	Current Assignee (Source: MaxVal’s Assignment Database[*])	Issue Date	Expiration Date[†]	Title
US6148232	Syneron	Nov 14, 2000	Sep 11, 2018	Transdermal drug delivery and analyte extraction
US6711435	Syneron	Mar 23, 2004	Sep 11, 2018	Transdermal drug delivery and analyte extraction

According the complaint, the defendant’s products with the 3DEEP technology and various handpieces used with those products including a) EndyMed Pro System and Fractional Skin Resurfacing handpiece and b) GLOW System and Fractional Skin Resurfacing handpiece infringe the above mentioned patents.

For more details, visit MaxVal-IP and subscribe to our Litigation Alerts.

---

[*]MaxVal offers Patent Assignment Alert service where subscribers receive email alerts when assignments relating to target applications, patents or entities of interest are recorded.

[†]Expected expiration date. Patent Term Estimator is a free web-based tool that automatically calculates patent terms and expiration dates for U.S. utility patents.